Swiss National Bank’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
140,400
+22,100
| +19% | +$210K | ﹤0.01% | 2001 |
|
|
2025
Q1 | $1.24M | Buy |
118,300
+9,700
| +9% | +$101K | ﹤0.01% | 2037 |
|
|
2024
Q4 | $2.56M | Buy |
108,600
+3,500
| +3% | +$82.5K | ﹤0.01% | 1717 |
|
|
2024
Q3 | $3.78M | Sell |
105,100
-800
| -0.8% | -$28.7K | ﹤0.01% | 1493 |
|
|
2024
Q2 | $3.74M | Buy |
105,900
+20,700
| +24% | +$731K | ﹤0.01% | 1446 |
|
|
2024
Q1 | $2.42M | Buy |
85,200
+25,000
| +42% | +$710K | ﹤0.01% | 1735 |
|
|
2023
Q4 | $801K | Sell |
60,200
-3,300
| -5% | -$43.9K | ﹤0.01% | 2353 |
|
|
2023
Q3 | $569K | Hold |
63,500
| – | – | ﹤0.01% | 2477 |
|
|
2023
Q2 | $714K | Buy |
63,500
+7,200
| +13% | +$81K | ﹤0.01% | 2458 |
|
|
2023
Q1 | $649K | Sell |
56,300
-6,200
| -10% | -$71.4K | ﹤0.01% | 2461 |
|
|
2022
Q4 | $724K | Buy |
62,500
+1,700
| +3% | +$19.7K | ﹤0.01% | 2482 |
|
|
2022
Q3 | $772K | Hold |
60,800
| – | – | ﹤0.01% | 2438 |
|
|
2022
Q2 | $418K | Buy |
60,800
+5,900
| +11% | +$40.6K | ﹤0.01% | 2654 |
|
|
2022
Q1 | $529K | Buy |
54,900
+3,900
| +8% | +$37.6K | ﹤0.01% | 2592 |
|
|
2021
Q4 | $606K | Hold |
51,000
| – | – | ﹤0.01% | 2629 |
|
|
2021
Q3 | $828K | Hold |
51,000
| – | – | ﹤0.01% | 2484 |
|
|
2021
Q2 | $1.07M | Buy |
+51,000
| New | +$1.07M | ﹤0.01% | 2446 |
|